NovalGen is an innovative immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer. NovalGen is focused on the development of cutting-edge, proprietary treatments for patients with hematologic malignancies and solid tumors by developing therapeutics that treat cancer using our breakthrough technologies in Bispecific antibodies and beyond

Therapeutics

Life Sciences

Biotechnology

Medical Devices

NovalGen

NovalGen's headquarters in Northwood Hills, United Kingdom

Description

People (3)

Jobs (0)

Other offices